quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:10·20d
SECFiling
VivoSim Labs Inc. logo

VivoSim Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

VIVS· VivoSim Labs Inc.
Health Care
Original source

Companies

  • VIVS
    VivoSim Labs Inc.
    Health Care

Related

  • SEC21d
    SEC Form 424B4 filed by VivoSim Labs Inc.
  • PR22d
    VivoSim Announces Pricing of up to a $4 Million Public Offering
  • SEC23d
    SEC Form EFFECT filed by VivoSim Labs Inc.
  • SEC23d
    Amendment: SEC Form S-1/A filed by VivoSim Labs Inc.
  • SEC27d
    SEC Form S-1 filed by VivoSim Labs Inc.
  • PR30d
    VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
  • PR51d
    VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
  • SEC71d
    SEC Form 10-Q filed by VivoSim Labs Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022